39%, p = 0.578), DCR (61 vs. 73%, p = 0.125), mPFS (4 vs. 3 months), and mOS (32 vs. 37 months, p = 0.630) between NRAS‐mutant melanoma and NRAS wild‐type melanoma [406]. Here, NRAS is linked to melanoma.